In conclusion, we report two cases of NTRK1 fusion-positive and seven cases of NTRK3 fusion-positive pediatric sarcomas and IMT that were diagnostically challenging without molecular features. This evidence concerns the gene NTRK3 and inflammatory myofibroblastic tumor.